Cancer Registry Software Market Size Worth $ 95.5 Million By 2026 | CAGR: 11.0%
/
/
Cancer Registry Software Market Size Worth $ 95.5 Million By 2026 | CAGR: 11.0%

Cancer Registry Software Market Size Worth $ 95.5 Million By 2026 | CAGR: 11.0%

The global Cancer Registry Software market size is expected to reach USD 95.5 million by 2026 according to a new study by WhipSmart Market Intelligence Research. The report “Cancer Registry Software Market by Type (Standalone, Integration), Delivery (On-premise, Cloud), Database (Commercial, Public), Functionality (Cancer Reporting, Patient Care, Medical Research), End User, By Regions, Segments & Forecast, 2019 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The report covers the COVID-19 impact on the Cancer Registry Software Market. The COVID-19 Impact analysis will help you to understand the future market growth in the Cancer Registry Software Market.

Growing prevalence of cancer also as favorable government initiatives, the marketplace for cancer registry software is growing. Other factors like the rising Use of cancer patient registry data for post-marketing surveillance also because the increasing number of accountable care organizations are adding to the expansion of the market. Other factors like the reluctance to adopt advanced solutions also as privacy and data security-related concerns are restraining the expansion of the general market.

The cancer registry software helps automate data collection for national and state registries, which further helps track effectiveness of various treatment approaches. Moreover, the info collected by the state registries helps understand and address the disease during a better way. The collected data is pivotal to focus on risk factors like tobacco use, sun exposure, or some environmental factors including chemical & radiation exposure. This information is additionally necessary for identifying locations where screening and treatment options should be tracked and improved. Moreover, registry data is beneficial for research institutes to estimate the efficiency of cancer control, treatment, & prevention program.

In the global Cancer Registry Software market, North America accounted for the most important share of the cancer patient registry software market. This regional market is additionally estimated to grow at a better rate during the forecast period. This will be attributed to the high burden of cancer, government funding initiatives to encourage the event of cancer registries, high investments in healthcare IT, presence of major cancer registry software-developing players, and therefore the high adoption rate of those solutions within the region.

The key players in the market Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), and McKesson Corporation (US) among others. Development of distribution channels, novel product development and aggressive marketing campaigning are some of the success factors in the industry.

 WhipSmart Market Intelligence Market research has segmented the Cancer Registry Software market report on the basis of product, end-user and region

Cancer Registry Software Type Outlook (Revenue, USD Million, 2019 – 2026)

  • Standalone Software
  • Integrated Software

Cancer Registry Software Deployment Model Outlook (Revenue, USD Million, 2019 – 2026)

  • On-Premise Models
  • Cloud Based Models

Cancer Registry Software Database Type Outlook (Revenue, USD Million, 2019 – 2026)

  • Commercial databases
  • Public Databases

Cancer Registry Software Functionality Type Outlook (Revenue, USD Million, 2019 – 2026)

  • Cancer Reporting to Meet State and Federal Regulations
  • Patient Care Management
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

Cancer Registry Software End-User Outlook (Revenue, USD Million, 2019 – 2026)

  • Government Organizations & Third-Party Administrators
  • Hospitals & Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

Cancer Registry Software Regional Outlook (Revenue, USD Million, 2019 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Russia
  • Asia Pacific
    • Japan
    • Korea
  • Latin America
    • Mexico
    • Brazil
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Israel
Share this post

There are no comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Start typing and press Enter to search

Shopping Cart

No products in the cart.